Cannabis medicine improved MS symptom in small studyPublished: 24 October 2022 People with multiple sclerosis (MS) who were treated with nabiximols – which contains compounds of the cannabis plant and is licenced in the UK under the brand name Sativex – saw their spasticity reduced and had improved arm and